Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria
Developing an Approach to Implementing Breast Cancer Screening Using Clinical Breast Exam in the Primary Health Centers of Abuja, Nigeria
2 other identifiers
observational
50
1 country
1
Brief Summary
The goal of this observational study is to engage with multilevel stakeholders to collaboratively and to systematically develop a suite of strategies for implementing breast cancer screening using clinical breast examination (CBE) in the primary health centers of Abuja, Nigeria. The main questions it aims to answer are: What barriers and facilitators exist to conducting screening CBE in Abuja's primary care setting and what implementation strategies would support CBE in primary care clinics? Participants will:
- Allow observation of study clinic workflows
- Participate in interviews and focus group discussions regarding screening CBE implementation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 23, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedNovember 13, 2025
November 1, 2025
7 months
June 30, 2025
November 12, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Intervention Domain Characteristics
Characteristics of routine clinical breast examination itself that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
1 year
Inner Setting Domain Characteristics
Characteristics of the primary care clinics that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
1 year
Outer Setting Domain Characteristics
Characteristics of both the community surrounding the clinics and the district-wide health system that are potential barriers and facilitators to screening implementation, , emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
1 year
Individuals Domain Characteristics
Characteristics of individuals involved in screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
1 year
Implementation Domain Characteristics
Characteristics of activities and strategies used to implement screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
1 year
Study Arms (3)
Adopters
Individuals responsible for deciding to institute screening CBE in Abuja's primary care clinics (e.g., policymakers, clinic administrators, nurse managers)
Implementers
Individuals responsible for actually performing the screening CBE in Abuja's primary care clinics (e.g., nurses, doctors, fieldworkers, clerical workers)
Recipients
Individuals eligible for a screening CBE (e.g., women over the age of 40 years from the community surrounding study clinics)
Eligibility Criteria
Focus group participants will consist of three categories: screening CBE "adopter" (e.g., clinic administrators/managers, department of health officials, etc), "implementers" (e.g., nurses, physicians, community health workers), and "recipients" (e.g., women from the community eligible for CBE screening and community breast cancer survivors). All participants will be drawn from the two study clinics in Abuja, Nigeria.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Yale Universitylead
- National Cancer Institute (NCI)collaborator
- University of Witwatersrand, South Africacollaborator
Study Sites (1)
Institute of Human Virology, Nigeria
Abuja, Nigeria
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel O'Neil, MD, MPH
Yale University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 23, 2025
Study Start
September 1, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
November 13, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
In order to comply with local legal requirements, individual participant data will not be available to other researchers.